In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback